BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 32517812)

  • 1. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
    Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
    BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus-triggered secondary hemophagocytic lymphohistiocytosis.
    Imashuku S; Morimoto A; Ishii E
    Acta Paediatr; 2021 Oct; 110(10):2729-2736. PubMed ID: 34096649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy.
    Yoon JH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Lee JW
    Haematologica; 2019 Feb; 104(2):269-276. PubMed ID: 30213834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
    Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
    Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
    Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
    Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
    Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
    J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A predictive model for identifying secondary underlying diseases of hemophagocytic lymphohistiocytosis.
    Gao WB; Hu LJ; Ma XL; Shi MJ; Wang CY; Ma Y; Song XJ; Zhu JH; Wang TB
    Front Immunol; 2023; 14():1143181. PubMed ID: 37187741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
    Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
    Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
    Song Y; Wang J; Wang Y; Wang Z
    Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis.
    Kim H; Mizuno K; Masuda K; Sakurai M; Ara T; Naito K; Uehara Y; Yamamoto G; Osada M; Machida S; Horio T; Fukushima K; Mori Y; Ichinohe T; Fukuda T; Atsuta Y; Kataoka K
    Transplant Cell Ther; 2024 Apr; 30(4):419.e1-419.e12. PubMed ID: 38266963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
    Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG.
    Wang X; Zhou Y; Sun Q; Zhou H; Zhang Q; Shen Z; Huang J; Xue Y; Yan D; Fang Y; Sang W
    Acta Haematol; 2023; 146(3):185-195. PubMed ID: 36623498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
    Li Y; Li S; Lu N; Wang W; Wang D
    Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.
    Koh KN; Im HJ; Chung NG; Cho B; Kang HJ; Shin HY; Lyu CJ; Yoo KH; Koo HH; Kim HJ; Baek HJ; Kook H; Yoon HS; Lim YT; Kim HS; Ryu KH; Seo JJ;
    Eur J Haematol; 2015 Jan; 94(1):51-9. PubMed ID: 24935083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.